Can You Get COVID-19 Twice?

February 18, 2024

Back
Featured image for “Can You Get COVID-19 Twice?”

As the COVID-19 pandemic continues into its third year, one question remains at the forefront of public discussion: can you get COVID-19 twice? Reinfection with the SARS-CoV-2 virus has been documented, but how common is it really? And what does it mean for immunity and the future course of the pandemic? This blog post will analyze the current research on COVID-19 reinfection rates, immunity duration, the role of emerging variants, and the implications for public health.

Introduction: Understanding COVID-19 Immunity

Acquiring immunity after an infection, through either natural infection or vaccination, is a complex immunological process. When the body encounters SARS-CoV-2 for the first time, the immune system activates and produces antibodies, B cells and T cells that help recognize the spike proteins on the surface of the virus and fight off the infection. This immunological memory also helps prevent or reduce the severity of future infections with the same virus.

However, the durability and strength of this immune memory can vary significantly by pathogen. Early evidence suggests immunity to coronaviruses wanes faster than other viruses like measles or smallpox. Determining the duration of natural and vaccine-induced immunity to COVID-19 is key for gauging risks of reinfection.

Documented Cases of COVID-19 Reinfection

While more data is still needed, several studies have confirmed that reinfection with COVID-19 is indeed possible. As of October 2022, over 90,000 probable global reinfections have been recorded across multiple countries out of more than 600 million confirmed COVID-19 cases to date. However, many experts say this is likely an undercount given the limitations around positive test reporting and public health tracking in many regions.

Most recorded reinfections have occurred within 3 to 6 months after an initial infection, but a number of cases with longer reinfection intervals (over one year) have also been documented. This indicates that while natural immunity from COVID-19 does provide some protection from reinfection, it can wane significantly over time.

Reinfection Rates and Severity

Looking more closely at reinfection rates estimates from studies around the world, there is considerable variability based on the region and time period analyzed:

  • 0.1% reinfection rate in Qatar (March 2020 – April 2021)
  • 0.7% reinfection rate in Denmark (March 2020 – May 2021)
  • 1.2% reinfection rate in England (June 2020 – May 2021)
  • 3.6% reinfection rate in Brazil (May 2020 – Nov 2020)
  • 7.3% reinfection rate in Austria (Sept 2020 – Nov 2021)

In general, reinfections seem to be less severe compared to primary infections and rarely result in hospitalization or death based on research from the CDC and UK health agencies. However, milder reinfection outcomes cannot be assumed, especially for vulnerable populations. The Omicron wave has also brought a sharp uptick in reinfections, hinting at increased immune evasion with new variants.

Artboard 1 13

Factors Affecting COVID-19 Reinfection Risk

What variables may influence someone’s susceptibility to contracting COVID-19 more than once? Here are key factors that researchers are investigating when it comes to SARS-CoV-2 immunity and reinfection likelihood:

Duration of Natural Immunity Over Time

  • Multiple studies show a significant waning of post-infection immunity antibodies within 6 to 8 months. However, the body also retains immune memory in B cells and T cells, which may still respond effectively to prevent reinfection. Determining this secondary immune response is complex.
  • In one study in the UK00628-0/fulltext), COVID-19 survivors had roughly 85-90% protection from reinfection for 10 months post-recovery but reinfection risk increased to nearly 20% at 12 months as natural immunity decreased further.

Emergence of New Virus Variants

  • The rapid spread of Alpha, Beta, Gamma, Delta and now Omicron variants demonstrates how SARS-CoV-2 continues to mutate and evolve over time into new strains.
  • Several lab studies indicate that certain mutations, especially on the viral spike protein targeted by antibodies, helps these variants partially bypass immune defenses primed by previous infection or vaccines designed around the original strain of the virus.
  • Monitoring real-world reinfection trends as new variants arise hints at some immune evasion leading to previously recovered individuals testing positive again at higher rates during huge variant-driven waves.

Individual Immune Response Differences

Research shows there is significant variation in post-infection immunity markers like neutralizing antibodies between individuals depending on factors such as:

  • Age and comorbidities
  • Severity of initial illness
  • Prior cross-reactive immunity from other coronaviruses

Although more investigation is required, some patterns are beginning to emerge that provide hints on who may be more susceptible to reinfection:

  • One study in Austria found age below 50, female sex and certain chronic conditions were associated with higher odds of confirmed reinfection.
  • Mild or asymptomatic initial infection may generate weaker natural immunity formation compared to recovery from severe COVID-19 illness.

Role of COVID-19 Vaccination

As mass vaccination campaigns continue globally, the interplay between natural immunity and vaccine-induced protection requires deeper attention:

  • Multiple studies have shown that while infection does provide measurable immune benefits for healthy individuals, vaccination post-recovery can still boost and broaden protection.
  • In particular, hybrid immunity from both natural infection and vaccination appears to offer stronger overall defenses against reinfection, signaling these immune layers are complementary and not strictly redundant.

There are still open questions around the efficacy of booster vaccination in preventing repeat infections as the protection from doses received over 6 months earlier fades over time. With widespread transmission ongoing, repeat exposures to newer variants could slowly erode immunity, suggesting that continued public health precautions and monitoring remains vital even in highly-vaccinated regions.

Public Health Implications of Documenting Reinfection

Consistently tracking COVID-19 reinfection events has larger value for policy decisions beyond just studying post-infection immunity alone:

  • Understanding risk factors allows identification of populations most vulnerable to repeat infections for targeted protection measures.
  • Analyzing immunity duration and waning helps guide appropriate timing for booster shots.
  • Spotting spikes in reinfection during new waves hints at which SARS-CoV-2 variants exhibit greater immune evasion capabilities.
  • Continual genomic surveillance together with reinfection data gives crucial signals around when existing vaccines and treatments could decline in efficacy against newer strains.

As the hoped-for transition point approaches from raging pandemic to endemic seasonal outbreaks, having robust longitudinal reinfection statistics will enable public health authorities to calibrate recommendations and interventions accordingly based on the latest developments.

Artboard 1 2

FAQs about COVID-19 Reinfection

How long does immunity last after getting infected with COVID-19?

While reinfection can happen as early as a few months post-recovery, studies indicate most individuals do retain some level of immunity for 6 to 12 months on average. However, there is high person-to-person variation in antibody duration and actual immune response may persist longer through cellular memory.

Can you still get reinfected with COVID-19 after being vaccinated?

Yes, reinfections after vaccination have occurred, especially breakthrough infections driven by the Delta and Omicron variant waves. However, studies consistently show vaccination provides about 75-90% protection against infection and over 90% protection against severe illness for at least 6 months, greatly reducing but not eliminating chances of reinfection. Booster doses provide additional but time-limited buffer against repeat infections.

How common and severe are second cases of COVID-19 reinfection?

As per studies tracking millions of COVID-19 survivors globally, the probability of testing positive a second time is estimated to be between 0.1% to 10% currently based on region. Reinfections are more likely with new concerning variants. Most second infections record mild to no symptoms but severe repeat infections have also been documented in some patients.

Do emerging SARS-CoV-2 variants increase COVID-19 reinfection risk?

Mounting lab and population data finds that mutations in variants like Beta, Delta and Omicron help these strains partially bypass immunity gained from older lineages. This immune evasion ability facilitates more double infections especially among those previously infected or vaccinated over 6 months earlier with the original SARS-CoV-2 strain targeted.

Could those who’ve had COVID-19 still benefit from vaccination?

Growing evidence shows that hybrid immunity from both natural infection and vaccination offers the strongest and most comprehensive protection against COVID-19 reinfection and severe complications. As immunity from a past infection can wane substantially after a year, getting vaccinated is advisable for those previously infected to prevent repeat infections especially with concerning virus variants that may evade the immune defenses primed by the first illness.

Conclusion and Key Takeaways

In conclusion, the likelihood of testing positive for COVID-19 more than once is extremely rare initially but seems to increase modestly over longer periods as natural immunity diminishes over time. Factors like waning antibodies, new variants and individual immunological differences can make reinfection more probable on a population level despite some ongoing protection from cellular memory.

  • Getting vaccinated even after recovery from COVID-19 augments immune defenses against reinfection.
  • Continual surveillance tracking reinfections, genomic evolution of the virus and waning of vaccine immunity over the long term is vital for effective ongoing public health management of the pandemic.
  • As population immunity reaches equilibrium between infections, vaccinations and reinfections in the coming months to years, the hope is SARS-CoV-2 comes to resemble endemic seasonal coronaviruses giving way to sustainable coexistence.
Rate this post

Related articles



Image
Image

MIRARI®
Cold Plasma System

The world's first handheld cold plasma device

Learn More


Made in USA

Image